From Doncaster Pharmaceuticals

From Doncaster Pharmaceuticals

From Doncaster Pharmaceuticals Group Limited, to Doncaster Pharma Limited, BModesto Group, are relaunching and rebranding Doncaster Pharmaceuticals Group Limited (DPGL) after a recent partial buyout.

Pilot scheme cycling and walking prescription

Pilot scheme cycling and walking prescription

A new pilot scheme will award 11 local authorities’ part of a £12.7 million sum to help them offer prescriptions for walking, cycling, and wheeling. The pilots are a commitment to the governments Gear Change Plan that was introduced in 2020.  The funding will...
Orphan medicines

Orphan medicines

Orphan medicines are medicinal products that are intended to treat diseases which are so uncommon that it would be difficult to secure funding for drug development under usual marketing conditions.

Conditional marketing authorisations

Conditional marketing authorisations

Conditional Marketing Authorisations (CMAs) were introduced in Great Britain as a scheme by the MHRA in January 2021. The CMAs can be granted for new medicinal products in GB whose benefits outweigh the potential risks of the new medicinal product.

Do you supply to Northern Ireland?

Do you supply to Northern Ireland?

Do you supply to customers in Northern Ireland – If you do, then you will be aware of a range of issues following Brexit and that we are still some way away from a long term agreement. However, we wanted to highlight a specific issue.